Effective management of migraine through ayurvedic techniques-a case report
Abstract
Migraine are one of the most common causes of functional disability worldwide, affecting approximately 16.6% of the global population. Women are three times more likely to experience migraines than men. This condition is marked by recurring headaches, often triggered by psychological and physiological stressors. Despite advance-ments in both modern and traditional medicine, a definitive cure remains elusive. In Ayurveda, migraine is clas-sified under Shiroroga (head-related disorders) and is referred to as Ardhavabhedaka. This case report focuses on a 31-year-old Indian housewife presenting with neck pain followed by recurrent right hemi-cranial headaches with vomiting occurring every fifth day for the past four years. The condition was diagnosed as Tridoshaja Ardhavabhedaka (migraine) associated with Amlapitta (hyperacidity). A comprehensive Ayurvedic treatment plan was implemented based on the dominant dosha (Dosha Pradhanyatha) and the disease stage (Vyadhi avastha). The therapeutic regimen included Nidana Parivarjana (avoidance of causative factors), Deepana (di-gestive stimulants), Paachana (digestive treatments), Siravyadha (bloodletting), Nasya (nasal therapy), and Dosha Shamana Chikitsa (pacification of doshas). The severity of the patient's migraine was evaluated using the Migraine Disability Assessment Scale (MIDAS), while pain levels were measured with the Numeric Pain Rating Scale (NPRS). Following treatment, there was a significant improvement, with the MIDAS…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.